Joel Erblich received a BA in psychology from the University of Maryland, a PhD in Clinical Psychology from the University of Southern California, and an MPH in biostatistics from Columbia University's School of Public Health. He completed a clinical psychology internship at the UCLA Neuropsychiatric Institute, where he specialized in adult and child health psychology and neuropsychology. After internship, Dr. Erblich completed two research-based postdoctoral fellowships: one in Biobehavioral Medicine at the Memorial-Sloan Kettering Cancer Center and one in Cancer Prevention and Control at the Mount Sinai School of Medicine. Continuing as a faculty member at Mount Sinai, Dr. Erblich's research focused on behavioral and genetic aspects of substance abuse, with a special emphasis on nicotine dependence. Dr. Erblich has an adjunct appointment at Mount Sinai, and is a member of the Mount Sinai Tisch Cancer Institute as well as the Mount Sinai Institute for Translational Epidemiology. His research focuses on the interactions among emotional, cognitive, behavioral and genetic factors in addictive behaviors. He takes a multidisciplinary-translational approach, with hypotheses driven by both the human and animal literatures that have contributed to the current understanding of motivations for drug use. Projects in this area include studies of the effects of dopamine-related genetic polymorphisms on smokers' cigarette cravings induced by laboratory stressors, conditioned cues/triggers, and other manipulations. Also studied are effects of family history, cognitive factors, and personality factors on smoking behavior, as well as effects of alcoholism and polysubstance abuse. The research draws upon behavioral principles, such as personality, conditioning, and stress reactivity, as well as molecular biological principles, including genetic and cellular mechanisms of dopamine transmission. It is anticipated that this research will lead to effective multifaceted treatments for tobacco smoking and alcohol dependence, both of which continue to contribute unabatedly to human morbidity and mortality at alarming rates.